Citations

Clear

940 citation(s) found for "Olson, JA".

Sex Differences in Exercise Capacity and Outcomes Following Outpatient Cardiac Rehabilitation
Chacin‐Suarez, Audry , Taylor, Jenna L. , Fischer, Karen M. , Bonikowske, Amanda R. , Squires, Ray W. , Thomas, Randal J. , Olson, Thomas P. , Smith, Joshua R , Medina-Inojosa, José R , Chacin Suarez, Audry S , Taylor, Jenna L , Fischer, Karen M , Bonikowske, Amanda , Thomas, Randal , Olson, Thomas , Smith, Joshua R. , Medina‐Inojosa, José R.

Mayo Clinic

Journal of the American Heart Association | July 17, 2026 | Volume: 15 | Issue: 14 | Pages: No page available

10.1161/jaha.125.044403 | PMID 42466484 Get It

Background Cardiac rehabilitation (CR) leads to increased exercise capacity (VO 2 peak) and risk reduction of major adverse cardiovascular events (MACEs). Women exhibit blunted VO 2 peak improvements following CR. The purpose was to examine sex differences in the clinical predictors of VO 2 peak improvement and odds of MACEs following CR. Methods From 1999 to 2017, all consecutive patients undergoing cardiopulmonary exercise testing before and after CR were included. Sex differences in peak exercise metrics in response to CR were compared. Multiple logistic regression models were fit to assess clinical predictors of VO 2 peak improvement (defined as >0% from pre‐CR) and MACEs following CR for men and women. Results A total of 513 men and 158 women were included. Men had greater increases in VO 2 peak than women following CR ( P =0.001). For men, independent predictors of VO 2 peak improvement following CR included higher CR session attendance (odds ratio [OR], 1.04 [95% CI, 1.02–1.06]), peripheral artery disease (OR, 0.47 [95% CI, 0.25–0.86]), and pre‐CR VO 2 peak (OR, 0.98 [95% CI, 0.97–0.99]) (all, P <0.02). Independent predictors of lower odds of MACEs following CR in men included higher number of CR sessions (OR, 0.97 [95% CI, 0.95–0.99]), pre‐CR VO 2 peak (OR, 0.98 [95% CI, 0.97–0.99]), surgical CR indication (OR, 0.34 [95% CI, 0.18–0.68]), and no history of peripheral artery disease (OR, 2.94 [95% CI, 1.60–5.38]) (all, P <0.02). For women, the selected clinical characteristics were not statistically significant independent predictors of VO 2 peak improvement or odds of MACEs (except for diabetes) following CR. Conclusions These findings suggest that clinical predictors of VO 2 peak improvement and odds of MACEs following CR are sex specific.
Development of a shared patient registry for measles exposure management amongst multiple stakeholder groups
Olson, Alyssa, Barth, Jean, Rasmusson, Jenna, Kriewall, Nicole, Kudrna, Cory, Sheley, Todd, Kramer, Tyler, Buckmeier, Jason, OHoro, John, Rasmusson, Jenna, Kriewall, Nicole E, Buckmeier, Jason R., O’Horo, John C.

Mayo Clinic

Antimicrobial Stewardship & Healthcare Epidemiology | July 17, 2026 | Volume: 6 | Issue: S1 | Pages: s189-s189

10.1017/ash.2026.10735 Get It

Background: We had a large-scale measles exposure event affecting 626 patients. Management of exposed patients was urgent, involving quarantine, post-exposure prophylaxis (PEP), and symptom monitoring on a case-by-case basis. Cases were initially tracked and managed using a combination of multiple spreadsheets amongst stakeholders as well as lists within the electronic health record (EHR). Using shared spreadsheets and lists created significant challenges with maintaining and editing multiple copies and updating workbooks simultaneously. Methods: Infection Prevention and Control (IPAC) worked with primary care personnel and EHR developers to create a shared registry that would prioritize communication and follow-up for exposed patients based on age and immunity. Patients are initially added to the shared registry within the EHR by reviewing non-registry reports and tagging patients, identified using exposure timeframes that overlapped with the index measles cases, in a manner that transferred them to the shared registry. From this registry, measles, mumps, and rubella vaccine status can be confirmed, immune status can be identified, and criteria for PEP assigned. High-risk patients are then contacted with recommendations from IPAC and primary care. Communication and follow-up are tracked directly within the shared registry to ensure appropriate patient management. The exposure management registry is further leveraged throughout the measles outbreak timeframe by allowing real-time monitoring of patients that require additional precautions or guidance related to their exposure. Result: The shared registry enhanced documentation accuracy and transparency between stakeholders. It led to availability of real-time status of exposed patients for the duration of the measles outbreak timeframe. Overall, the registry enabled time-sensitive patient communication to all exposed patients and rapid identification of those who needed PEP. Communication could happen rapidly and seamlessly between care teams within the organization, and the necessary information could be shared quickly with public health authorities as required. Conclusion: Large scale exposures are a challenge to manage and ensure appropriate action and communication occurs. Errors can be prevented by having a single shared exposure management registry. A registry enables care teams to quickly identify and prioritize patients for measles follow-up, communication, PEP, and ongoing management across outbreak timeframes. This process reduces both time and operational burdens of exposure follow-up tracking outside of the EHR.
Prevention of Secondary Cases after a Measles Exposure at an Academic Medical Center
Barth, Jean, Siple, Leah, Olson, Alyssa, Rasmusson, Jenna, Faller, Rebecca, Meyer, Michelle, Baxter, Becky, Loberg, Emily, Apenhorst, Debra, Higbe, Leah, Mahler, Sarah Bellows, Maurer, Sheryl, Whitehurst, Heidi, Paden, Felice, Higbe, Sheila, OHoro, John, Levy, Emily, Huskins, W. Charles, Sampathkumar, Priya , Rasmusson, Jenna, Apenhorst, Debra, Beam, Elena , O’Horo, John C. , Huskins, W. Charles

Mayo Clinic

Antimicrobial Stewardship & Healthcare Epidemiology | July 17, 2026 | Volume: 6 | Issue: S1 | Pages: s176-s176

10.1017/ash.2026.10710 Get It

Background: Measles is a highly transmissible virus. A single case can result in significant exposures within a healthcare facility and prompt action is needed to prevent secondary cases. In October 2025, Infection Prevention and Control (IPAC) was notified of a patient being admitted to our facility with recent international travel and symptoms consistent with measles. The patient was unvaccinated and had five healthcare facility visits prior to measles being suspected and subsequently confirmed. Objective: To describe our facility’s effective identification, prioritization, and prophylaxis of individuals exposed to measles. Methods: IPAC leveraged the electronic medical record to identify potentially exposed patients. Patients were quickly assessed for age and immune status, then prioritized and assigned to primary care teams. These teams promptly contacted patients and coordinated PEP administration. Results: Across five encounters, the index patient exposed 539 other patients. Due to delayed notification, our teams had less than four days to administer PEP for those exposed and still within PEP window. PEP administration began within hours of the index case’s positive test and patients received PEP within three days (Table 1). No secondary measles cases occurred within our facility. Conclusion: Timely and coordinated multidisciplinary effort enabled us to rapidly respond to our first measles case and control secondary transmission. Although the index case resulted in a large exposure, patients that were exposed and eligible for PEP were quickly prioritized to prevent secondary transmission.
Performance Improvement in Healthcare Facility Measles Management
Siple, Leah, Barth, Jean, Faller, Rebecca, Olson, Alyssa, Rasmusson, Jenna, Meyer, Michelle, Baxter, Becky, Loberg, Emily, Higbe, Leah, Apenhorst, Debra, Mahler, Sarah Bellows, OHoro, John, Levy, Emily, Huskins, W. Charles, Sampathkumar, Priya , Rasmusson, Jenna, Apenhorst, Debra, Beam, Elena , O’Horo, John C. , Huskins, W. Charles

Mayo Clinic

Antimicrobial Stewardship & Healthcare Epidemiology | July 17, 2026 | Volume: 6 | Issue: S1 | Pages: s154-s155

10.1017/ash.2026.10679 Get It

Background: Advanced planning and adaptable response strategies are essential for preventing measles transmission in healthcare facilities. Objective: To describe a measles management plan and subsequent modifications in response to a cluster of measles cases. Methods: Drawing on previously published work (doi:10.1017/ice.2025.49), the Infection Prevention and Control (IPAC) team initiated a multi-disciplinary team and developed a measles preparedness plan with the following domains: Guidance and education; early detection and testing; isolation and patient movement; contact tracing and exposure management (Table 1). In October 2025, a patient was admitted during their fifth healthcare encounter and was diagnosed with measles. Two family members were later hospitalized with measles. Delayed recognition of the first case prompted enhancements to our preparedness framework (Table 1). Results: The first case resulted in 539 exposed patients. The second resulted in 87 exposures, and the third resulted in no exposure. Despite the extensive exposure, zero secondary measles were reported. Conclusion: Proactive planning enabled rapid response to our first case and controlled secondary transmission. Despite extensive planning, delayed identification of the first case caused significant exposures. As the cluster unfolded, we refined our plan, resulting in zero exposures from the last patient and zero secondary cases, despite over 850 exposures. These efforts may guide other healthcare facilities in improving their measles preparedness and response.
Developing a Measles Flagging System within the Electronic Health Record
Rasmusson, Jenna, Sampathkumar, Priya , OHoro, John, Barth, Jean, Olson, Alyssa, Nelson, Ben, Faller, Rebecca, Siple, Leah, Rasmusson, Jenna, O’Horo, John C.

Mayo Clinic

Antimicrobial Stewardship & Healthcare Epidemiology | July 17, 2026 | Volume: 6 | Issue: S1 | Pages: s154-s154

10.1017/ash.2026.10678 Get It

Background: In 2025, 50 measles outbreaks drove 87% of confirmed cases reported in the United States. As a highly infectious virus with an estimated R ranging from 12-18, we sought rapidly scalable and implementable measles preparedness measures for our facilities. Methods: The electronic health record (EHR) has flags that can be placed on patient records to denote the presence of, or concern for, active, transmissible infections. These flags are highly visible in the EHR and represent a good usability heuristic as front line providers are already trained to look for this information. Infection Prevention and Control (IPAC) worked with nursing informatics to develop measles-specific flags for suspected, confirmed and exposed patients in the EHR, expanding flagging functionality in preparation for potential measles cases and exposures. The flagging was tied to registry functionality to allow for tracking of exposed and confirmed cases longitudinally for supporting IPAC investigations in addition to clinical operations. Results: Three different flags were developed in the EHR to address measles. Specific criteria were created for each flag, as shown in Table 1. Table 1: Attached as Image Conclusion: As a highly contagious virus, measles presents unique challenges to healthcare facilities managing both cases and exposures. Measles flags within the EHR can be leveraged to assist facilities with case tracking, exposure management, and infection prevention and control.
Implementing Admission Screening for Candida auris
Rasmusson, Jenna, Sampathkumar, Priya , Wengenack, Nancy, Meyer, Michelle, Olson, Alyssa, Rasmusson, Jenna, Wengenack, Nancy L.

Mayo Clinic

Antimicrobial Stewardship & Healthcare Epidemiology | July 17, 2026 | Volume: 6 | Issue: S1 | Pages: s113-s114

10.1017/ash.2026.10611 Get It

Background: Candida auris is a globally emerging, multidrug-resistant fungal pathogen that causes serious, difficult-to-treat infections in hospitalized patients. C. auris cases in the United States have been linked to receipt of healthcare overseas. Outbreaks have also occurred in New York City, New Jersey, Illinois, Nevada, and California. We provide care to patients from all 50 states and 138 countries and are therefore, at risk for encountering C.auris within our facility. Methods: A case-finding tool was created by Infection Prevention and Control (IPAC) within the electronic medical record (EMR) to identify patients for screening. Inclusion criteria was centric to patients who were admitted in the previous 24 hours with a primary address in a foreign country or in areas of the United States with known C. auris transmission. Patients who are positive for Carbapenamase-producing organisms (CPO) are also included in screening criteria. In 2020, Clinical Microbiology validated a polymerase chain reaction (PCR) test in partnership with the State Health Department and IPAC. In January 2022, IPAC created a protocol that allows IPAC staff to order C. auris screening directly in the EMR utilizing the validated PCR test. The order is paired with communication from IPAC alerting the patient care team that C.auris screening is indicated. Instructions on test collection and information on C. auris are also included in messaging. The patient’s primary nurse then obtains verbal consent from the patient to collect a composite axilla–groin skin swab. Swabs are sent to Clinical Microbiology for testing, and results are reported directly into the EMR. Results: Since the introduction of the nursing protocol in January 2022, 2,660 patients have been identified for C. auris screening through November 2025. Of the 2,660 patients identified for testing, 1,111 patients had screening completed. Two patients tested positive for C. auris on screening. Both patients had prolonged travel to regions with known C. auris transmission. Conclusion: The EMR can be leveraged for early identification and screening of patients at risk of C.auris colonization. Case finding tools, combined with nursing protocols and communication strategies within the EMR can be effectively replicated and modified to respond to emerging infections.
Leveraging the Electronic Medical Record to Identify Patients at Risk for Carbapenemase-producing organisms
Rasmusson, Jenna, Barth, Jean, Apenhorst, Debra, Mahler, Sarah Bellows, Siple, Leah, Olson, Alyssa, Meyer, Michelle, Faller, Rebecca, Sampathkumar, Priya , Rasmusson, Jenna, Apenhorst, Debra

Mayo Clinic

Antimicrobial Stewardship & Healthcare Epidemiology | July 17, 2026 | Volume: 6 | Issue: S1 | Pages: s113-s113

10.1017/ash.2026.10610 Get It

Background: Carbapenemase-producing organisms (CPO) are a serious public health threat. The Centers for Disease Control and Prevention (CDC) guidelines for combating CPO includes a recommendation to screen selected high risk patients. We describe a program to identify and screen patients at risk for CPO. Setting: An academic, tertiary care center with 2,059 licensed beds and 74,359 admissions a year. Methods: A report was created in the electronic medical record (EMR) to identify adult patients admitted in the previous 24 hours who were from countries and states with known CPO transmission based on address and zip code. A nursing protocol was subsequently developed in the EMR to facilitate CPO screening for eligible patients at admission. After the CPO order is placed, an electronic communication is sent via the EMR alerting the patient care team of the order, the rationale for screening, details on swab collection, and links to a toolkit with resources to help answer patient questions. A single perirectal swab is obtained by the patient’s primary nurse and is tested for Klebsiella pneumoniae Carbapenemase (KPC), New Delhi metallo-β-lactamase (NDM), oxacillinase-48 (OXA-48), and Verona integron-encoded metallo-β-lactamase (VIM) by polymerase chain reaction (PCR). Patients may refuse testing. Results: From May 2018 through November 2025, 6,039 patients were identified for CPO screening using case-finding report. Of these patients, 2,424 had CPO swabs completed. Eighteen patients with CPO were identified with an overall yield of 0.75% on admission screening. There was one patient who tested positive for KPC, 10 patients who tested positive for NDM, and 5 patients who tested positive for OXA-48. Two patients were identified to have both NDM and OXA-48. Conclusions: The EMR can be leveraged for early identification and screening of patients with epidemiologically significant pathogens. Use of the nursing protocol has enabled IPAC to complete timely CPO surveillance and prevent transmission to other patients. Protocols within the EMR can be effectively replicated for a timely response to emerging infections.
Impact of inspiratory muscle training on inspiratory muscle metaboreflex in patients with heart failure with preserved ejection fraction
Miller, Sophie , Hammer, Shane M. , Bruhn, Eric J., Olson, Thomas P., Miller, Sophie A, Smith, Joshua R , Borlaug, Barry A. , Olson, Thomas P. , Smith, Joshua R.

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | July 17, 2026 | Volume: 331 | Issue: 2 | Pages: R283-R290

10.1152/ajpregu.00114.2026 | PMID 42463142 Get It

Heart failure with preserved ejection fraction (HFpEF) is associated with exercise intolerance, with respiratory muscle dysfunction as a contributing factor. Patients with HFpEF have exaggerated cardiovascular responses to respiratory muscle metaboreflex activation. In this study, we determined the impact of inspiratory muscle training (IMT) on the respiratory muscle metaboreflex in HFpEF. We found that 8 wk of IMT improved inspiratory muscle strength and attenuated the respiratory muscle metaboreflex-mediated cardiovascular responses in patients with HFpEF.
MAGIC Composite Score Predicts Outcomes of Second-Line Therapy for Acute GVHD
Sebastian, Tara, Weber, Daniela, Etra, Aaron M., Vasova, Ingrid, Ayuk, Francis, Choe, Hannah K., DeFilipp, Zachariah, Quagliarella, Francesco, Bedirian, Karni, Diniz, Marcio Augusto, Aguayo-Hiraldo, Paibel, Bader, Peter, Baez, Janna, Chanswangphuwana, Chantiya, Eng, Gilbert, Francke, Thomas, Hexner, Elizabeth O., Katsivelos, Nikolaos, Kitko, Carrie L., Kraus, Sabrina, Louloudis, Ioannis E., Morales, George, Nakamura, Ryotaro, Olson, Timothy S., Qayed, Muna, Reddy, Pavan, Reshef, Ran, Schechter, Tal, Wang, Tingyu, Wolf, Matthias, Young, Rachel, Zeiser, Robert, Hogan, William J., Levine, John E., Ferrara, James L.M., Sebastian, Tara M. , Weber, Daniela , Etra, Aaron , Vášová, Ingrid, Ayuk, Francis , Choe, Hannah , DeFilipp, Zachariah , Quagliarella, Francesco , Bedirian, Karni, Aguayo‐Hiraldo, Paibel , Bader, Peter , Baez, Janna , Chanswangphuwana, Chantiya , Eng, Gilbert, Francke, Thomas, Hexner, Elizabeth O. , Katsivelos, Nikolaos , Kitko, Carrie L. , Kraus, Sabrina , Morales, George , Nakamura, Ryotaro , Olson, Timothy S. , Qayed, Muna , Reddy, Pavan, Reshef, Ran , Schechter, Tal , Wölfl, Matthias , Young, Rachel , Zeiser, Robert , Hogan, William J. , Levine, John E. , Ferrara, James L.M.

Mayo Clinic

No container title available | July 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.07.09.26357664 | PMID 42523406 Get It

ABSTRACT Approximately 30% of patients with acute graft-versus-host disease (GVHD) develop steroid-refractory disease and have very poor outcomes. Ruxolitinib has become the standard of care for steroid-refractory acute GVHD, but it is unclear which patients derive benefit. The MAGIC Composite Score (MCS), an algorithm that combines clinical symptoms and biomarkers, has been validated to predict outcomes at the start of primary GVHD treatment. Here, we evaluated its performance at the initiation of second-line treatment in 278 patients. MCS stratified patients into three risk groups (MCS1-3), with the majority (88%) classified as intermediate or high risk. Increasing MCS score was associated with progressively higher 1-year non-relapse mortality (NRM) rates (16%, 41%, and 73%; p<0.001), lower 1-year survival (77%, 56%, and 24%; p<0.001), and lower complete response (CR) rates at day 28 (47%, 38%, and 20%, respectively; p<0.01). The area under the receiver operating characteristic curve (AUROC) for 1-year NRM was significantly higher with MCS compared to clinical symptoms alone (0.70 vs. 0.63; p=0.023). Among patients treated with ruxolitinib, higher MCS similarly predicted higher NRM and lower survival and CR rates. Patients classified as MCS2/3 had poor outcomes despite ruxolitinib, underscoring the need for novel therapies in this patient population. In conclusion the MCS is an accurate predictor of outcomes for patients who require second-line treatment and may be of use as an eligibility criterion for future clinical trials in this high-risk population. Key Points MAGIC Composite Scores that integrate clinical symptoms and biomarker scores predict outcomes of second-line therapy for acute GVHD more accurately than clinical symptoms alone. MCS identifies patients with high NRM despite treatment with ruxolitinib.
A Cost-Effective High Task Alignment Model for Ultrasound-Guided Central Venous Catheterization Training
Gomaa, I, Damon, Aaron, Chorro, Rosa Anna, Olson, Helga N, Johnson, Jimmy A. , Stites, A. C., Rivera, Mariela , Kelm, D, Gomaa, Ibrahim A. , Stites, Andrew J , Morrey, Mark, Kelm, Diana, Damon, Aaron , Morrey, Mark E. , Kelm, Diana J.

Mayo Clinic

ATS Scholar | July 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/atsscholar/aapag033 | PMID 42406409 Get It

Abstract Background Central venous catheterization (CVC) is a fundamental procedural competency in pulmonary and critical care medicine (PCCM). Although commercially available task trainers are effective for teaching CVC placement, their high cost and logistical requirements can limit access to repeated practice. Objective To evaluate learner and faculty perceptions and usability of a newly developed CVC simulation model compared with a standard commercial task trainer and detail the technical report of the novel model’s construction. Methods We conducted a prospective educational evaluation during the PCCM CVC workshop. Participants practiced CVC placement with both the standard commercial trainer and a locally constructed simulation model developed at our institution. Teaching faculty were asked to evaluate both models from an instructional standpoint. Results Eighteen participants (15 PCCM 1st year fellows and 3 faculty instructors) evaluated the novel CVC simulation model. All fellows (n = 15, 100%) preferred the new model over a standard commercial model, with 14 (93%) reporting improved understanding of CVC insertion steps and 11 (73%) noting ease of ultrasound landmark identification. All fellows (n = 15, 100%) endorsed inclusion of the model in future workshops. Additionally, faculty instructors preferred the novel model for teaching (n = 3, 100%). All faculty supported future use of the model. The initial model development cost was approximately $288.96 with most materials’ reusable. Conclusions The novel task-aligned CVC simulation model offers a realistic, reusable, and cost-effective alternative to commercial simulators, with high learner and faculty preference and strong educational value. Its functional alignment supports integration into fellowship training, with future studies needed to assess objective skill acquisition and retention.